Arafeen Aisha | University of Majmaah (original) (raw)

Papers by Arafeen Aisha

Infezioni in Medicina

ID-19, which evolved from the SARS-CoV wild-type virus. Several novel variations developed during... more ID-19, which evolved from the SARS-CoV wild-type virus. Several novel variations developed during the COVID-19 pandemic, some of which are known as Variants of Concern (VOC). VOCs are classified as Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2), and Omicron (B.1.1.529) by WHO [1]. These five SARS-CoV-2 VOCs have a substantial level of pathogenicity and transmissibility. New SARS-CoV-2 variants widely recognized as variations of interest (VOI) have been determined based on their transmissibility, severity of sickness, diagnostic escape, and immunological escape. In December 2019, the severe acute respiratory syndrome 2 (SARS-CoV-2) coronavirus outbreak began in Wuhan, China, and quickly spread to practically every corner of the globe, killing millions of people. SARS-CoV-2 produced numerous variants, five of which have been identified as variants of concern (VOC) by the World Health Organization (WHO) (Alpha, Beta, Gamma, Delta, and Omicron). We conducted a comparative epidemiological analysis of SARS-CoV-2 and its VOC in this paper. We compared the effects of vari-SUMMARY ous spike (S) protein mutations in SARS-CoV-2 and its VOC on transmissibility, illness severity, hospitalization risk, fatality rate, immunological evasion, and vaccine efficacy in this review. We also looked into the clinical characteristics of patients infected with SARS-CoV-2 and its VOC.

Journal of the Korean Radiological Society, 2008

A secretory carcinoma of the breast is a rare, but clinically and histologically a distinct varia... more A secretory carcinoma of the breast is a rare, but clinically and histologically a distinct variant of the invasive ductal carcinoma, which has a slow growth pattern and a favorable prognosis. Few studies have reported the radiologic findings involved in a secretory carcinoma of the breast. We report the imaging findings of a secretory carcinoma of the breast in a 48-year-old woman, which were similar to those of a benign mass found on a mammography and sonography.

Secretory Carcinoma of the Breast, 2016

Secretory carcinoma of the breast is a rare variant with excellent prognosis and indolent clinica... more Secretory carcinoma of the breast is a rare variant with excellent prognosis and indolent
clinical behavior. At the microscopic level, the presence of intracellular and extracellular
secretory material is the most remarkable feature.We report a case of secretory carcinoma
of the breast in a 90 year old female, with classic cytological findings.
Key words: secretory carcinoma, cytological findings

Infezioni in Medicina

ID-19, which evolved from the SARS-CoV wild-type virus. Several novel variations developed during... more ID-19, which evolved from the SARS-CoV wild-type virus. Several novel variations developed during the COVID-19 pandemic, some of which are known as Variants of Concern (VOC). VOCs are classified as Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2), and Omicron (B.1.1.529) by WHO [1]. These five SARS-CoV-2 VOCs have a substantial level of pathogenicity and transmissibility. New SARS-CoV-2 variants widely recognized as variations of interest (VOI) have been determined based on their transmissibility, severity of sickness, diagnostic escape, and immunological escape. In December 2019, the severe acute respiratory syndrome 2 (SARS-CoV-2) coronavirus outbreak began in Wuhan, China, and quickly spread to practically every corner of the globe, killing millions of people. SARS-CoV-2 produced numerous variants, five of which have been identified as variants of concern (VOC) by the World Health Organization (WHO) (Alpha, Beta, Gamma, Delta, and Omicron). We conducted a comparative epidemiological analysis of SARS-CoV-2 and its VOC in this paper. We compared the effects of vari-SUMMARY ous spike (S) protein mutations in SARS-CoV-2 and its VOC on transmissibility, illness severity, hospitalization risk, fatality rate, immunological evasion, and vaccine efficacy in this review. We also looked into the clinical characteristics of patients infected with SARS-CoV-2 and its VOC.

Journal of the Korean Radiological Society, 2008

A secretory carcinoma of the breast is a rare, but clinically and histologically a distinct varia... more A secretory carcinoma of the breast is a rare, but clinically and histologically a distinct variant of the invasive ductal carcinoma, which has a slow growth pattern and a favorable prognosis. Few studies have reported the radiologic findings involved in a secretory carcinoma of the breast. We report the imaging findings of a secretory carcinoma of the breast in a 48-year-old woman, which were similar to those of a benign mass found on a mammography and sonography.

Secretory Carcinoma of the Breast, 2016

Secretory carcinoma of the breast is a rare variant with excellent prognosis and indolent clinica... more Secretory carcinoma of the breast is a rare variant with excellent prognosis and indolent
clinical behavior. At the microscopic level, the presence of intracellular and extracellular
secretory material is the most remarkable feature.We report a case of secretory carcinoma
of the breast in a 90 year old female, with classic cytological findings.
Key words: secretory carcinoma, cytological findings